SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-19-013745
Filing Date
2019-09-05
Accepted
2019-09-05 17:28:59
Documents
17
Period of Report
2019-09-04
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 31817
2 ex99-2.htm EX-99.2 13696
3 ex99-2_001.jpg GRAPHIC 52420
4 ex99-2_002.jpg GRAPHIC 222819
5 ex99-2_003.jpg GRAPHIC 73856
6 ex99-2_004.jpg GRAPHIC 88160
7 ex99-2_005.jpg GRAPHIC 59721
8 ex99-2_006.jpg GRAPHIC 122003
9 ex99-2_007.jpg GRAPHIC 96983
10 ex99-2_008.jpg GRAPHIC 141067
11 ex99-2_009.jpg GRAPHIC 129155
12 ex99-2_010.jpg GRAPHIC 104473
13 ex99-2_011.jpg GRAPHIC 87725
14 ex99-2_012.jpg GRAPHIC 124877
15 ex99-2_013.jpg GRAPHIC 81164
16 ex99-2_014.jpg GRAPHIC 84685
17 ex99-2_015.jpg GRAPHIC 121415
  Complete submission text file 0001493152-19-013745.txt   2238490
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37648 | Film No.: 191078056
SIC: 2835 In Vitro & In Vivo Diagnostic Substances